The Mount Sinai experience with orthotopic liver transplantation for benign tumors: brief report and literature review: case reports.
Orthotopic liver transplantation (OLT) is performed for benign hepatic lesions that are symptomatic, too large to be resected, have a malignant transformation potential, cause debilitating/life-threatening manifestations, or in patients experiencing posthepatectomy acute liver failure. Among benign tumors, polycystic liver disease (PLD) is the most common indication for OLT alone, or combined liver-kidney transplantation. Our 10-year experience with OLT for benign tumors includes two patients with PLD and one with a benign giant fibrous tumor. In this report, we present our experience with OLT for benign liver tumors, commenting on relevant published studies.
Schwartz
M E
ME
Recanati-Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY, USA.
Roayaie
S
S
Konstadoulakis
M M
MM
Gomatos
I P
IP
Miller
C M
CM
D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery*; D016031:Liver Transplantation / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000175:diagnosis; D011183:Postoperative Complications; D016896:Treatment Outcome